ALBUQUERQUE, N.M. (KRQE) – Scientists at the University of New Mexico are developing a new treatment for chronic pain. They’ve received a $1 million grant to create a novel antibody they hope can reduce pain responses. The research focuses on a hormone, cholecystokinin (CCK), a peptide hormone, found in the stomach and the brain that aggravates nerve cells. If successful, the antibody would block the effects of that hormone.
Story Continues Below
- Crime: Repeat speeder arrested after going 140 mph down Montgomery
- Albuquerque: Police search for tips in Albuquerque shooting following Walmart altercation
- Weather: Very windy today with cooler temps and chance for showers
- New Mexico: Crew member who gave Baldwin gun subject of prior complaint
- Español: KRQE En Español: Lunes 25 de Octubre 2021
The two-year grant award came from the National Institutes of Health Helping to End Addiction Long-Term (HEAL) Initiative. It’s already been tested on mice. According to a news release from UNM Health Sciences, if the project hits its anticipated progress in the first two years it can be extended for three more years and then be tested in humans.
For more information, visit hsc.unm.edu/news/2021/10/developing-novel-antibody-chronic-pain.